What is the accuracy (sensitivity and specificity) of an HSV IgG test performed 3–4 weeks after exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

HSV IgG Testing at 3–4 Weeks Post-Exposure: Accuracy

An HSV IgG test performed at 3–4 weeks after exposure is unreliable and will miss a substantial proportion of true infections because antibodies typically do not become detectable until at least 12 weeks post-exposure. 1

Critical Timing Issue

The fundamental problem with testing at 3–4 weeks is the antibody development window:

  • Detectable IgG antibodies may not appear until up to 12 weeks after HSV exposure, making any serology obtained before this timeframe prone to false-negative results 1
  • Guidelines explicitly state that serologic testing should be performed ≥12 weeks after suspected exposure to avoid missing true infections 1
  • Testing performed earlier than 12 weeks should be deferred, with repeat testing recommended no sooner than 12 weeks after the suspected exposure 1

Baseline Test Performance (Even at Optimal Timing)

Even when performed at the recommended ≥12-week timeframe, HSV IgG tests have significant limitations:

HSV-1 IgG Accuracy

  • Sensitivity: approximately 70% (meaning ~30% false-negative rate even in truly infected individuals) 1
  • Recent 2024 data confirms sensitivities <85% for commonly used automated assays (Roche, Bio-Rad) 2
  • At 3–4 weeks, this already poor sensitivity becomes even worse because antibodies have not yet developed 1

HSV-2 IgG Accuracy

  • Sensitivity: approximately 92% (~8% false-negative rate in established infections) 1
  • Specificity varies dramatically by index value: only 39.8% at low index values (1.1–2.9), improving to 78.6% at index values ≥3.0 1
  • Recent studies show sensitivities >97% and specificities >98% for some platforms (Roche, Bio-Rad) when antibodies are present 2
  • However, at 3–4 weeks post-exposure, these performance metrics are irrelevant because antibodies have not yet formed 1

Real-World Implications at 3–4 Weeks

At 3–4 weeks post-exposure, you are testing during the seronegative window period:

  • A negative result is essentially meaningless and cannot exclude infection 1
  • A positive result, if it occurs, likely represents a pre-existing infection rather than the recent exposure in question 1
  • Studies of patients with PCR-confirmed recurrent genital herpes found that 12–30% remained seronegative on commercial gG-based assays even months after infection 3

Clinical Recommendation

Do not perform HSV IgG serology at 3–4 weeks post-exposure. Instead:

  • If active lesions are present, obtain HSV NAAT/PCR directly from the lesion (>90% sensitivity and specificity, distinguishes HSV-1 from HSV-2) 4
  • If no lesions are present, wait until at least 12 weeks post-exposure before ordering serology 1
  • Even at 12 weeks, clinicians must counsel patients that a negative HSV-1 result has only ~70% sensitivity and a negative HSV-2 result has ~92% sensitivity 1
  • When clinical suspicion remains high despite negative serology at ≥12 weeks, consider repeat testing or await lesion development for direct NAAT/PCR 1

Key Pitfall to Avoid

Never tell a patient that a negative HSV serology at 3–4 weeks excludes recent exposure—the test is being performed during the antibody development window and will miss the vast majority of acute infections. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.